# QualityMetric Incorporated QualityMetric Incorporated is an Asset Manager based in Johnston, United States. ## Overview - **Organization type:** Asset Manager - **Headquarters:** Johnston, United States - **Region:** North America - **Address:** Johnston, RI, United States - **Founded:** 1997 - **Assets under management:** Undisclosed - **Website:** qualitymetric.com ## Regulatory record - **Reports private funds:** No ## About Founded in 1997 by John E. Ware Jr., PhD — the lead architect of the SF-36 questionnaire during his tenure at RAND and the Health Institute — QualityMetric Incorporated commercialized the health-status measurement tools widely regarded as the gold standard for patient-reported outcomes. Ware's academic work established the conceptual framework for quantifying health-related quality of life across eight domains, including physical functioning, bodily pain, and mental health. The company was headquartered in Johnston, Rhode Island, and operated as a for-profit enterprise licensing proprietary survey instruments and scoring algorithms to clinical trial sponsors, health systems, and government agencies. The firm's core intellectual property included the SF-36v2, SF-12v2, and SF-8 Health Surveys, which produced norm-based scores enabling cross-population comparisons. QualityMetric's business model centered on software licensing, electronic data capture platforms, and analytical services that translated raw patient-reported data into validated health outcomes metrics. Its tools were embedded in thousands of clinical trials, observational studies, and population health initiatives globally, with particular adoption in the United States, Western Europe, and Japan. The company also developed disease-specific instruments and dynamic assessment technologies that reduced respondent burden through item-response theory and computerized adaptive testing. QualityMetric was acquired by Ingenix, a UnitedHealth Group subsidiary that later rebranded as OptumInsight, in February 2010. Terms of the transaction were not publicly disclosed. Following the acquisition, the QualityMetric portfolio was integrated into Optum's broader health analytics and outcomes research offerings, where it contributes patient-reported data to real-world evidence generation and value-based care contracting. John E. Ware Jr. remained active in health outcomes research after the acquisition, serving as a consultant and advisor on measurement science initiatives. What sets QualityMetric's legacy apart is its depth of peer-reviewed validation — the SF-36 alone has been cited in tens of thousands of published studies, creating a moat of academic credibility that generic survey platforms cannot replicate. This unusually thick evidence base transformed a questionnaire into an embedded piece of regulatory and reimbursement infrastructure, now operating inside one of the largest health data organizations in the world. ## Sectors - Health Outcomes & Patient-Reported Data ## Questions ### How did QualityMetric become part of UnitedHealth Group? Ingenix, a UnitedHealth Group subsidiary focused on health data and analytics, acquired QualityMetric in February 2010. Ingenix was subsequently rebranded as OptumInsight, and QualityMetric's survey assets were folded into Optum's outcomes research and real-world evidence capabilities. The purchase price was not publicly disclosed. ### Does QualityMetric operate independently today? No. QualityMetric no longer operates as a stand-alone entity. Since its 2010 acquisition by UnitedHealth Group, its intellectual property and survey platforms have been managed within OptumInsight, where they contribute to health economics and outcomes research services offered to biopharmaceutical clients, government agencies, and integrated delivery networks. ### What was QualityMetric's business model before the acquisition? The company generated revenue through software licensing, usage fees for electronic survey administration and scoring, and analytical consulting services tied to its proprietary health-survey instruments (SF-36v2, SF-12v2, SF-8). Its client base included pharmaceutical companies running global clinical trials, academic research consortia, and integrated health systems tracking population-level health outcomes. ## Related profiles - [Melancthon Capital](https://altss.com/profile/melancthon-capital) - [Accelerate Change](https://altss.com/profile/accelerate-change) --- Last updated: 2026-06-03T20:00:00.000Z Canonical page: https://altss.com/profile/qualitymetric-incorporated Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology